Vizilite Cancer Screening
The ViziLite® TBlue® system helps Dr. Boskovic and Dr. Srbinovska identify, evaluate, monitor and mark abnormal oral cell lesions suspicious for pathology, including precancerous and cancerous cells that may be difficult to see during a regular visual exam.
The ViziLite TBlue Advantage system is quick and easy to use, only taking two minutes during a standard visual examination in our Tustin, CA office. The small device size enables easier access to see and focus light inside the oral cavity. The disposable technology eliminates cross-contamination and improves infection control. A clinical study has shown the use of ViziLite TBlue resulted in no false negative outcomes, meaning in the study ViziLite TBlue identified every lesion that had precancerous or cancerous cells. The study also determined that ViziLite TBlue significantly reduced the number of false positive lesions identified during standard visual examinations, limiting the number of biopsies that may have been performed.
Dr. Boskovic and Dr. Srbinovska use the pre-rinse solution in ViziLite TBlue to desiccate the cells to make the nuclei more prominent and, therefore, more visible. The low intensity light from the handheld light source is reflected off of the abnormal cells down to the basement membrane where the nuclei have been rendered more prominent and appear to "glow," making abnormal cells easier to see.